Barclays PLC
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| BCY.DE | HSBC | NA.TO | SAN | CM | WBC.F | |
|---|---|---|---|---|---|---|
| Market cap | 66.83B | 323.43B | 78.18B | 192.28B | 102.12B | 74.65B |
| P/E (TTM) | 9.0 | 13.5 | 17.1 | 12.9 | 15.0 | 18.8 |
| Forward P/E | — | 9.9 | 14.2 | 9.3 | 14.0 | — |
| Price/book | 0.9 | 7.5 | 2.4 | 1.6 | 2.2 | 1.7 |
| Dividend yield | 2.60% | 3.97% | 2.59% | 2.09% | 2.68% | 4.33% |
| 1-year change | +22.78% | +44.01% | +33.92% | +34.75% | +39.31% | −0.58% |
| Today | −2.32% | +0.03% | −0.06% | −1.19% | +0.20% | +1.18% |
The closest companies by business and industry (Banks - Diversified). Prices may be delayed up to 15 min.
Latest news
All BCY.DE news ›Fastenal Company (FAST) Gets a Hold from Barclays
Barclays analyst Guy Hardwick maintained a Hold rating on Fastenal Company today and set a price target of $46.00. According to TipRanks, Hardwick is a 5-star analyst with an average return of 16.5% and a 72.22% success rate. Hardwick…
Barclays Remains a Hold on HCA Healthcare (HCA)
In a report released today, Andrew Mok CFA from Barclays maintained a Hold rating on HCA Healthcare, with a price target of $387.00. Mok CFA covers the Healthcare sector, focusing on stocks such as Aveanna Healthcare Holdings, Addus…
Barclays Remains a Buy on Marsh & McLennan Companies (MRSH)
Barclays analyst Alex Scott maintained a Buy rating on Marsh & McLennan Companies today and set a price target of $206.00. According to TipRanks, Scott is a 5-star analyst with an average return of 8.1% and a 60.31% success rate. Scott…
Barclays Keeps Their Buy Rating on Datadog (DDOG)
Barclays analyst Raimo Lenschow maintained a Buy rating on Datadog today and set a price target of $300.00. Lenschow covers the Technology sector, focusing on stocks such as Salesforce, HubSpot, and Atlassian. According to TipRanks,…
Collegium Pharmaceutical (COLL) Receives a Buy from Barclays
Barclays analyst Jenna Davidner maintained a Buy rating on Collegium Pharmaceutical today and set a price target of $48.00. Davidner covers the Healthcare sector, focusing on stocks such as Collegium Pharmaceutical, Xeris Pharmaceuticals,…
Datadog price target raised to $300 from $290 at Barclays
Barclays raised the firm’s price target on Datadog (DDOG) to $300 from $290 and keeps an Overweight rating on the shares. The firm adjusted targ... Datadog price target raised to $300 from $290 at Barclays Barclays raised the firm’s price…
Barclays Keeps Their Buy Rating on Fervo Energy Company Class A (FRVO)
Barclays analyst David Anderson maintained a Buy rating on Fervo Energy Company Class A today and set a price target of $48.00. According to TipRanks, Anderson is a 4-star analyst with an average return of 7.3% and a 51.30% success rate.…
Cummins (CMI) PT Lowered to $675 at Barclays
Barclays analyst Adam Seiden lowered the price target on Cummins (NYSE: CMI) to $675.00 (from $760.00) while maintaining a Overweight rating. StreetInsider.com Top Tickers, 10/19/2026 - Wall Street tumbles as worries about AI trade and…
Barclays Keeps Their Buy Rating on Hyatt Hotels (H)
In a report released today, Brandt Montour from Barclays maintained a Buy rating on Hyatt Hotels, with a price target of $202.00. Montour covers the Consumer Cyclical sector, focusing on stocks such as Viking Holdings, Boyd Gaming, and…
Perfect Run Continues | Manchester City v Brighton Highlights | Barclays WSL 2026-27
Barclays WSL Watch the highlights as Manchester City win a five-goal thriller against Brighton. Follow us on: Facebook: [https://www.facebook.com/BarclaysWSL](https://www.facebook.com/BarclaysWSL) X:…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
marketscreener.com147
-
gurufocus.com80
-
marketbeat.com74
-
tradingview.com68
-
theglobeandmail.com44
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.